BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:40:00 PM | Browse: 837 | Download: 575
Publication Name World Journal of Gastroenterology
Manuscript ID 4842
Country United States
Received
2013-07-26 11:26
Peer-Review Started
2013-07-26 13:43
To Make the First Decision
2013-08-21 18:38
Return for Revision
2013-08-22 19:23
Revised
2013-08-27 09:30
Second Decision
2013-09-03 14:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-09-04 07:25
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-11-01 08:41
Publish the Manuscript Online
2013-12-18 09:53
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Mesenteric vein thrombosis in a patient heterozygous for factor Ⅴ Leiden and G20210A prothrombin genotypes
Manuscript Source Invited Manuscript
All Author List Paras Karmacharya, Madan Raj Aryal and Anthony Donato
Funding Agency and Grant Number
Corresponding Author Paras Karmacharya, MD, Department of Internal Medicine, 6th avenue and Spruce Street, Reading Health System, West Reading, PA 19611, United States. paraskarmacharya@gmail.com
Key Words Mesenteric vein thrombosis; Prothrombin gene; Factor V Leiden; Heterozygous; Anticoagulation; Oral contraceptives
Core Tip The common presence of two thrombophilic defects increases the thrombotic risk several folds above the risk of a single defect and these tend to occur at an earlier age as seen in our case. Also the risk of recurrent thrombosis is significantly increased among these heterozygotes. Indefinite anticoagulation with oral anticoagulants (goal International Normalized Ratio = 2-3) is recommended for high risk patients like our case with thrombosis at unusual sites (e.g., mesenteric vein), and heterozygosity for both factor V Leiden and prothrombin G20210A mutations. These patients should avoid any hormonal therapy and family members should be screened for underlying prothrombotic condition.
Publish Date 2013-12-18 09:53
Citation Karmacharya P, Aryal MR, Donato A. Mesenteric vein thrombosis in a patient heterozygous for factor Ⅴ Leiden and G20210A prothrombin genotypes. World J Gastroenterol 2013; 19(43): 7813-7815
URL http://www.wjgnet.com/1007-9327/full/v19/i43/7813.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i43.7813
Full Article (PDF) WJG-19-7813.pdf
Manuscript File 4842-Review.docx
Answering Reviewers 4842-Answering reviewers.pdf
Copyright License Agreement 4842-Copyright assignment.pdf
Peer-review Report 4842-Peer review(s).pdf
Scientific Editor Work List 4842-Scientific editor work list.doc